SCHEMBL1720160

SCHEMBL1720160

Cc1cccc(C(c2ccccc2)c2ccc(N(c3ccc(C(c4ccccc4)c4cccc(C)c4)cc3)c3ccc(C(c4ccccc4)c4cccc(C)c4)cc3)cc2)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.44
ACP3 P15309 1/20 0.44
ACHE P22303 1/20 0.38
SLC6A2 P23975 2/20 0.38
SLC6A4 P31645 2/20 0.38
MGAM O43451 1/20 0.38
GAA P10253 1/20 0.38
SI P14410 1/20 0.38
MGAM2 Q2M2H8 1/20 0.38
AOC3 Q16853 1/20 0.37
TP53 P04637 2/20 0.36
DRD4 P21917 1/20 0.36
TAAR1 Q96RJ0 1/20 0.36
EPHX1 P07099 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
OPRM1 P35372 1/20 0.35
OPRD1 P41143 1/20 0.35
OPRK1 P41145 1/20 0.35
OPRL1 P41146 1/20 0.35
KDM4E B2RXH2 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10001260 0.95 MAPT (0.42) MAPTACP3ACHESLC6A2SLC6A4
SCHEMBL13721176 0.95 MAPT (0.42) MAPTACP3ACHESLC6A2SLC6A4
SCHEMBL22251502 0.94 EPHX1 (0.42) MAPTACP3ACHESLC6A2SLC6A4
SCHEMBL2609918 0.91 EPHX1 (0.40) MAPTACP3SLC6A2SLC6A4MGAM
SCHEMBL17808641 0.91 EPHX1 (0.40) MAPTACP3SLC6A2SLC6A4MGAM
SCHEMBL10259894 0.91 EPHX1 (0.40) MAPTACP3SLC6A2SLC6A4MGAM
SCHEMBL14285388 0.91 EPHX1 (0.40) MAPTACP3SLC6A2SLC6A4MGAM
SCHEMBL12239142 0.89 SLC6A2 (0.40) MAPTACP3ACHESLC6A2SLC6A4
SCHEMBL16625482 0.88 EPHX1 (0.39) MAPTACP3SLC6A2SLC6A4MGAM
SCHEMBL10092973 0.88 EPHX1 (0.39) MAPTACP3SLC6A2SLC6A4MGAM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230240135-A1 HETEROCYLIC COMPOUND, LIGHT-EMITTING DEVICE INCLUDING THE HETEROCYCLIC COMPOUND AND ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2023-07-27 US disclosed
US-20230240135-A1 HETEROCYLIC COMPOUND, LIGHT-EMITTING DEVICE INCLUDING THE HETEROCYCLIC COMPOUND AND ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2023-07-27 US disclosed
EP-1486549-B1 ORGANIC ELECTROLUMINESCENT ELEMENT TOYOTA JIDOSHOKKI KK (JP) 2012-01-11 EP disclosed
US-7338720-B2 Organic electroluminescent element KABUSHIKI KAISHA TOYOTA JIDOSHOKKI (JP) 2008-03-04 US disclosed
US-20050089713-A1 Organic electroluminescent element KABUSHIKI KAISHA TOYOTA JIDOSHOKKI (JP) 2005-04-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230240135-A1 HETEROCYLIC COMPOUND, LIGHT-EMITTING DEVICE INCLUDING THE HETEROCYCLIC COMPOUND AND ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE CRY1, LAGE3, NQO1 MAPT 4078/4885ACP3 4860/4885ACHE 100/4885
US-20050089713-A1 Organic electroluminescent element SOD3, CELF2, SOD1 MAPT 3933/4885ACP3 3300/4885ACHE 786/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.